C

D

CARGNELUTTI , Daniela

Last name: CARGNELUTTI

First name: Daniela

2022 (v1)

Publication

Metadata-only

Long-term follow-up (up to 11 years) of an Italian pediatric MS cohort treated with Natalizumab: a multicenter, observational study

Baroncini, Damiano Ghezzi, Angelo Guaschino, Clara

Background Natalizumab (NAT) has a strong impact on disease activity of aggressive pediatric multiple sclerosis (MS), with no difference in safety profile compared to adult MS. However, available data are limited by short follow-up. Our aim was to report long-term follow-up data (up to 11 years) of a large Italian pediatric MS cohort treated...

Uploaded on: February 16, 2024